Telix Pharmaceuticals (TLX) Doses First Patient in Phase 3 Trial for Brain Cancer Therapy

On: April 19, 2026, 12:27 pm EDT

URL has been copied successfully!

Share this story:

Previous Post:Are You a Rich Household? Here's The Income It Takes To Be Poor, Middle Class, Or Wealthy

Next Post:Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy